These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29074302)

  • 1. Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fcγ receptor genes.
    Pandey JP; Namboodiri AM; Wolf B; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Immunobiology; 2018 Feb; 223(2):178-182. PubMed ID: 29074302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls.
    Pandey JP; Namboodiri AM; Armeson KE; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Hum Immunol; 2018 Aug; 79(8):632-637. PubMed ID: 29879453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral Immunity to Cytomegalovirus Glycoprotein B in Patients With Breast Cancer and Matched Controls: Contribution of Immunoglobulin γ, κ, and Fcγ Receptor Genes.
    Pandey JP; Gao G; Namboodiri AM; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    J Infect Dis; 2016 Feb; 213(4):611-7. PubMed ID: 26410593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer.
    Pandey JP; Namboodiri AM; Kistner-Griffin E; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Clin Exp Immunol; 2013 Mar; 171(3):273-7. PubMed ID: 23379433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG and FcγR genotypes and humoral immunity to mucin 1 in prostate cancer.
    Pandey JP; Namboodiri AM; Kistner-Griffin E
    Hum Immunol; 2013 Aug; 74(8):1030-3. PubMed ID: 23619475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGKC and FcγR genotypes and humoral immunity to HER2 in breast cancer.
    Pandey JP; Kistner-Griffin E; Black L; Namboodiri AM; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Immunobiology; 2014 Feb; 219(2):113-7. PubMed ID: 24054945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer.
    Pandey JP; Nietert PJ; Klaamas K; Kurtenkov O
    Cancer Immunol Immunother; 2009 Dec; 58(12):2025-9. PubMed ID: 19365631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
    von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
    J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer.
    Pandey JP; Nietert PJ; von Mensdorff-Pouilly S; Klaamas K; Kurtenkov O
    Cancer Res; 2008 Jun; 68(11):4442-6. PubMed ID: 18519707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
    Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
    Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer.
    Pandey JP; Namboodiri AM; Mohan S; Nietert PJ; Peterson L
    Cell Immunol; 2017 Feb; 312():67-70. PubMed ID: 27825564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
    Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
    Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
    Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma.
    Pandey JP; Kistner-Griffin E; Radwan FF; Kaur N; Namboodiri AM; Black L; Butler MA; Carreon T; Ruder AM
    Neuro Oncol; 2015 May; 17(5):678-84. PubMed ID: 25326496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
    Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women.
    Croce MV; Isla-Larrain MT; Capafons A; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2001 Sep; 69(1):1-11. PubMed ID: 11759823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
    Gilewski T; Adluri S; Ragupathi G; Zhang S; Yao TJ; Panageas K; Moynahan M; Houghton A; Norton L; Livingston PO
    Clin Cancer Res; 2000 May; 6(5):1693-701. PubMed ID: 10815887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.
    Hamanaka Y; Suehiro Y; Fukui M; Shikichi K; Imai K; Hinoda Y
    Int J Cancer; 2003 Jan; 103(1):97-100. PubMed ID: 12455059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.
    Ibrahim NK; Yariz KO; Bondarenko I; Manikhas A; Semiglazov V; Alyasova A; Komisarenko V; Shparyk Y; Murray JL; Jones D; Senderovich S; Chau A; Erlandsson F; Acton G; Pegram M
    Clin Cancer Res; 2011 Nov; 17(21):6822-30. PubMed ID: 21878535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.